tenXclinical, founded in 2023, is carving a niche in the fast-evolving landscape of clinical trial operations through cutting-edge technologies. Operating from the United States, the company excels in offering solutions that enhance efficiency and accessibility in workflows for teams and participants on a global scale.
Specializing within an interdisciplinary array of sectors such as AI, Biotechnology, EdTech, Pharmaceutical, and Machine Learning, tenXclinical is poised for significant impact. The company's slogan, "Clinical trial operations technologies," captures its mission succinctly.
Recent financial backing includes a $50.00K Pre Seed Round investment, secured on 15 July 2023, underscoring early confidence from the investor community. This infusion of capital is expected to propel tenXclinical in its objective to revolutionize clinical research operations.